Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
-499.38%
NET PROFIT MARGIN AVG 15Y
-673.94%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Edesa Biotech, Inc.
Market Cap
$37.81M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$38.31M
Net Profit Margin
0.00%
TTM Avg
-27258.72%
3Y Avg
-52085.61%
5Y Avg
-35139.97%
Market Cap
$37.14M
Net Profit Margin
-12.24%
TTM Avg
-6.29%
3Y Avg
-4.54%
5Y Avg
-3.49%
Market Cap
$38.90M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
Market Cap
$36.38M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$36.32M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$35.82M
Net Profit Margin
426.93%
TTM Avg
106.45%
3Y Avg
-19.31%
5Y Avg
-30.13%
Market Cap
$35.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$40.28M
Net Profit Margin
-689.20%
TTM Avg
-248.90%
3Y Avg
-225.94%
5Y Avg
-1945.52%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| Incannex Healthcare Limited (IXHL)vs › | $38.31M | 0.00% | -27258.72% | -52085.61% | -35139.97% |
| Accuray Incorporated (ARAY)vs › | $37.14M | -12.24% | -6.29% | -4.54% | -3.49% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.90M | -11.86% | -39.34% | -22.53% | -16.34% |
| DocGo Inc. (DCGO)vs › | $36.38M | -65.29% | -26.68% | -11.11% | -8.71% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | 0.00% | 0.00% | 0.00% | -479.12% |
| Elutia Inc (ELUT)vs › | $35.82M | 426.93% | 106.45% | -19.31% | -30.13% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -689.20% | -248.90% | -225.94% | -1945.52% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.01M | 0.00% | 0.00% | 0.00% | -1673.30% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | -402899.60% |
| 2020-06-30 | -1605.46% |
| 2020-03-31 | -1347.89% |
| 2019-12-31 | -1015.15% |
| 2019-09-30 | -232.45% |
| 2019-06-30 | -258801.40% |
| 2019-03-31 | -1406.71% |
| 2018-12-31 | -2650.62% |
| 2018-09-30 | -2080.84% |
| 2018-06-30 | -1583.33% |
| 2018-03-31 | -2111.61% |
| 2017-12-31 | -6837.24% |
| 2017-09-30 | -42393.68% |
| 2017-06-30 | -5943.70% |
| 2017-03-31 | -1751.34% |
| 2016-12-31 | -1047.31% |
| 2016-09-30 | -485.76% |
| 2016-06-30 | -659.38% |
| 2016-03-31 | -263.84% |
| 2015-12-31 | -333.87% |
| 2015-09-30 | -766.19% |
| 2015-06-30 | 294.13% |
| 2015-03-31 | -227.13% |
| 2014-12-31 | -631.75% |
| 2014-08-31 | -3885.66% |
| 2014-05-31 | 1767.67% |
| 2014-02-28 | -261.19% |
| 2013-11-30 | -9093.17% |
| 2013-08-31 | -3153.80% |
| 2013-05-31 | -1600.15% |
| 2013-02-28 | -5926.92% |
| 2012-11-30 | -661.78% |
| 2012-08-31 | -5170.51% |
| 2012-05-31 | -2607.92% |
| 2012-02-29 | -1450.39% |
| 2011-11-30 | -501.05% |
| 2011-08-31 | -2784.17% |
| 2011-05-31 | -3120.85% |
| 2011-02-28 | -697.32% |
| 2010-11-30 | -1235.10% |
| 2010-08-31 | -29.32% |
| 2010-05-31 | -209.57% |
| 2010-01-31 | 0.00% |
| 2009-10-31 | 0.00% |
| 2009-04-30 | 0.00% |
| 2009-01-31 | 0.00% |
| 2008-10-31 | 0.00% |
